318 related articles for article (PubMed ID: 17433870)
1. New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.
Sundrud MS; Rao A
Curr Opin Immunol; 2007 Jun; 19(3):287-93. PubMed ID: 17433870
[TBL] [Abstract][Full Text] [Related]
2. Plasticity of CD4+ T cell lineage differentiation.
Zhou L; Chong MM; Littman DR
Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
[TBL] [Abstract][Full Text] [Related]
3. Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy.
Capietto AH; Martinet L; Cendron D; Fruchon S; Pont F; Fournié JJ
J Immunol; 2010 Jun; 184(12):6680-7. PubMed ID: 20483742
[TBL] [Abstract][Full Text] [Related]
4. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.
Wahl SM; Swisher J; McCartney-Francis N; Chen W
J Leukoc Biol; 2004 Jul; 76(1):15-24. PubMed ID: 14966194
[TBL] [Abstract][Full Text] [Related]
7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
8. IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells.
Hebel K; Rudolph M; Kosak B; Chang HD; Butzmann J; Brunner-Weinzierl MC
J Immunol; 2011 Dec; 187(11):5627-35. PubMed ID: 22048775
[TBL] [Abstract][Full Text] [Related]
9. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation.
Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
Int Immunol; 2008 Nov; 20(11):1361-8. PubMed ID: 18820263
[TBL] [Abstract][Full Text] [Related]
10. Th17 cell differentiation: the long and winding road.
McGeachy MJ; Cua DJ
Immunity; 2008 Apr; 28(4):445-53. PubMed ID: 18400187
[TBL] [Abstract][Full Text] [Related]
11. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
Acosta-Rodriguez EV; Napolitani G; Lanzavecchia A; Sallusto F
Nat Immunol; 2007 Sep; 8(9):942-9. PubMed ID: 17676045
[TBL] [Abstract][Full Text] [Related]
12. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells.
Holzer U; Rieck M; Buckner JH
J Autoimmun; 2006 Jun; 26(4):241-51. PubMed ID: 16730947
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional basis of lymphocyte tolerance.
Borde M; Barrington RA; Heissmeyer V; Carroll MC; Rao A
Immunol Rev; 2006 Apr; 210():105-19. PubMed ID: 16623767
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta-mediated immunoregulation.
Peng Y; Gorelik L; Laouar Y; Li MO; Flavell RA
Ernst Schering Res Found Workshop; 2006; (56):155-60. PubMed ID: 16329651
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta as a T cell regulator in colitis and colon cancer.
Becker C; Fantini MC; Neurath MF
Cytokine Growth Factor Rev; 2006; 17(1-2):97-106. PubMed ID: 16298544
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta as a promising option in the treatment of multiple sclerosis.
Mirshafiey A; Mohsenzadegan M
Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
[TBL] [Abstract][Full Text] [Related]
17. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta in T-cell biology.
Gorelik L; Flavell RA
Nat Rev Immunol; 2002 Jan; 2(1):46-53. PubMed ID: 11905837
[TBL] [Abstract][Full Text] [Related]
19. Synergistic and combinatorial control of T cell activation and differentiation by transcription factors.
Sundrud MS; Nolan MA
Curr Opin Immunol; 2010 Jun; 22(3):286-92. PubMed ID: 20399089
[TBL] [Abstract][Full Text] [Related]
20. NFAT in lymphocytes: a factor for all events?
Serfling E; Berberich-Siebelt F; Avots A
Sci STKE; 2007 Aug; 2007(398):pe42. PubMed ID: 17684296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]